Related Experiment Video
Updated: Dec 24, 2025

Assessing Activity-based Anorexia in Mice
Published on: May 14, 2018
Metabotropic glutamate receptor 5 in bulimia nervosa
Yoan Mihov1,2, Valerie Treyer3, Funda Akkus1
1Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
Abstract:
Bulimia nervosa (BN) shares central features with substance-related and addictive disorders. The metabotropic glutamate receptor subtype 5 (mGlu5) plays an important role in addiction. Based on similarities between binge eating and substance-related and addictive disorders, we investigated mGlu5 in vivo in 15 female subjects with BN and 15 matched controls. We measured mGlu5 distribution volume ratio (DVR) with positron emission tomography (PET) using [11 C]ABP688. In BN mGlu5 DVR was higher in the anterior cingulate cortex (ACC), subgenual prefrontal cortex, and straight gyrus (p < 0.05). In BN, higher mGlu5 DVR in various brain regions, including ACC, pallidum, putamen, and caudate, positively correlated with "maturity fears" as assessed using the Eating Disorder Inventory-2 (p < 0.05). In BN and controls, smokers had globally decreased mGlu5 DVR. We present the first evidence for increased mGlu5 DVR in BN. Our findings suggest that pharmacological agents inhibiting mGlu5 might have a therapeutic potential in BN.
More Related Videos
Related Concept Videos
Bulimia Nervosa
Binge Eating Disorders
Pathophysiology of Vomiting
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Ligand-Gated Ion Channel Receptor: Gating Mechanism

